
Montana Cannabis Sales Top $327M in 2024, Surpass $1B Total
Adult-use market dominates as medical sales decline in fourth year of legalization
Montana's adult-use cannabis market posted record sales of $327 million in 2024, pushing the state's total cannabis revenue past $1 billion since recreational sales launched in 2022.
The milestone comes as Montana's market undergoes a significant shift—adult-use now accounts for roughly 80% of all cannabis transactions, with medical marijuana sales steadily declining as patients migrate to the recreational program.
Montana voters approved recreational cannabis in November 2020, but sales didn't begin until January 2022 due to regulatory setup. In those first two years, medical sales still held strong. But 2024 marked a turning point, with adult-use revenue nearly quadrupling the medical market's contribution.
The Numbers
The $327 million in adult-use sales represents a 23% increase over 2023, when recreational purchases totaled $266 million. Medical marijuana sales, meanwhile, dropped to approximately $82 million in 2024, down from $95 million the previous year.
Montana's per-capita cannabis spending now rivals established markets like Colorado and Oregon. With a population of roughly 1.1 million, the state generated nearly $300 per resident in adult-use sales alone—a figure that suggests both robust local consumption and possible tourism impact from neighboring states without legal cannabis.
The state collected an estimated $49 million in cannabis tax revenue in 2024, based on Montana's 20% excise tax on recreational sales. Those funds are distributed to conservation programs, substance abuse treatment, veterans services, and local governments.
Market Maturation
The shift from medical to adult-use reflects a pattern seen across dual-market states. Many registered medical patients have let their cards lapse, opting instead for the convenience of recreational dispensaries that don't require doctor visits or registry fees.
Montana currently has approximately 450 licensed cannabis businesses, including cultivators, processors, and retailers. The state caps the number of retail licenses based on population, with most concentrated in Billings, Missoula, and Great Falls.
Unlike some states that restricted early licensing to existing medical operators, Montana allowed new entrants to apply for adult-use licenses. This created a competitive landscape but also led to market saturation in some regions, with several dispensaries closing in 2023 after overestimating demand.
What's Next
Montana lawmakers are considering changes to the state's cannabis tax structure in the 2025 legislative session. One proposal would reduce the excise tax from 20% to 15% to improve competitiveness with neighboring markets and reduce illicit sales.
Industry advocates also want clearer rules around cannabis banking and interstate commerce, though federal prohibition limits state-level solutions. Montana banks have been relatively accommodating compared to other states, but many dispensaries still operate largely in cash.
The Montana Department of Revenue will release detailed 2024 sales data by product category and region in March, which should provide clearer insights into consumer preferences and geographic trends.
For now, Montana's billion-dollar milestone cements its position as one of the Mountain West's most successful adult-use programs—and a case study in how quickly medical markets can be eclipsed once recreational sales begin.
This article is based on original reporting by mjbizdaily.com.
Original Source
This article is based on reporting from MJBizDaily.
Read the original articleOriginal title: "Montana adult-use cannabis sales hit record $327 million"
Related Topics
Related Stories
BusinessJetty Extracts Eyes New York Expansion After California Survival
California extract brand Jetty Extracts is expanding to New York after surviving the state's cannabis market collapse through patient-focused products and conservative growth. CEO Nate Ferguson discusses the company's strategy.
BusinessCannabis Companies Warned Against Stock Buybacks Amid Capital Crunch
Industry analysts are questioning whether share repurchase programs make strategic sense for cannabis companies facing capital constraints, high debt costs, and limited access to traditional financing.
LegislationVirginia Moves Closer to Legal Cannabis Sales as Bills Advance
Virginia's House and Senate advanced companion bills to legalize cannabis sales, moving the legislation closer to Governor Youngkin's desk despite his previous opposition.
More from Alex Morgan
View all articles
Bob Weir's Nuanced Cannabis Stance Defied 'Drug Band' Stereotypes

Rescheduling Won't Fix Cannabis Industry Without Insurance Access

Chicago's Cannabis Run Club Grows From 'Highdea' to Weekly Tradition

